Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets (Unaudited)

v3.20.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 252,906 $ 293,484
Short-term deposits 55,300 28,300
Accounts receivable, net 103,693 132,558
Inventories 152,685 168,504
Prepaid expenses 7,568 6,567
Other current assets 19,209 29,659
Total current assets 591,361 659,072
Non-current assets    
Property, plant and equipment, net 198,521 189,706
Goodwill 385,658
Other intangible assets, net 65,083 87,328
Operating lease right-of-use assets 18,905 20,936
Other non-current assets 35,238 38,819
Total non-current assets 317,747 722,447
Total assets 909,108 1,381,519
Current liabilities    
Accounts payable 23,478 35,818
Accrued expenses and other current liabilities 26,462 28,528
Accrued compensation and related benefits 28,536 34,013
Deferred revenues 47,288 52,268
Operating lease liabilities - short term 8,675 9,292
Total current liabilities 134,439 159,919
Non-current liabilities    
Deferred revenues - long-term 13,436 16,039
Operating lease liabilities - long term 10,600 12,445
Other non-current liabilities 33,291 35,343
Total non-current liabilities 57,327 63,827
Total liabilities 191,766 223,746
Contingencies (see note 11)
Redeemable non-controlling interests 568 622
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 55,112 thousands shares and 54,441 thousands shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 150 148
Additional paid-in capital 2,722,839 2,706,894
Accumulated other comprehensive loss (9,289) (7,716)
Accumulated deficit (1,996,926) (1,542,175)
Total equity 716,774 1,157,151
Total liabilities and equity $ 909,108 $ 1,381,519